We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

$11M Study to Jumpstart Radiation Exposure Drug Development

News   Jan 16, 2019 | Original story from the University of Nebraska

 
$11M Study to Jumpstart Radiation Exposure Drug Development

Researchers Becky Deegan and Kenneth Bayles of the University of Nebraska Medical Center and David Berkowitz of the University of Nebraska chemistry department are jumpstarting the development of drug therapies to protect military service members from the effects of radiation exposure. The same therapies could be used to protect cancer patients receiving radiation treatments. Photo taken in the Department of Radiation Oncology at the Fred & Pamela Buffett Cancer Center in Omaha, Nebraska. Credit: Craig Chandler, University of Nebraska-Lincoln

 
 
 

RELATED ARTICLES

Japan Approves Stem Cell Therapy for Spinal Cord Injuries

News

A stem cell therapy has been given the green light for the treatment of spinal cord injuries, and a follow-up trial is set to begin later this year. However, independent researchers warn that the approval is premature.

READ MORE

Multi-organ "Human-on-a-Chip" Enables Long-term Toxicology Testing

News

The microfluidic device with interlinking modules containing human-derived heart, liver, skeletal muscle and nervous system cells was able to maintain cellular viability and record cellular function in real-time for 28 days.

READ MORE

Human Gene Linked to a Better Recovery From Stroke

News

Neuroscientists have found that patients born without a gene called CCR5 recover better from mild stroke than patients with the gene.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE